Depression: Does nutrition have an adjunctive treatment role?

Nutrition and Dietetics

Volumn 63, Issue 4, 2006, Pages 213-226

  Volker, Dianne ^a,c   Ng, Jade ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Goodman Fielder Pty Ltd   (Australia)

^c NONE   (Australia)

Author keywords

Clinical nutrition; Diet education; Diet practice; Diet therapy; Fatty acid; Nutritional research

Indexed keywords

EID: 33751061258     PISSN: 14466368     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0080.2006.00109.x     Document Type: Review

References (103)

1. Jorm A, Korten A, Jacomb P, Christensen H, Rodgers B, Pollitt P. Mental health literacy: A survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. Med J Aust 1997; 166: 182-6.
2. Ellis P, Smith D. Treating depression: The beyondblue guidelines for treating depression in primary care. Med J Aust 2002; 176: S77-83.
3. Black Dog Institute. (Cited Nov 2005.) Available from URL: http://www.blackdoginstitute.org.au/depression
4. Thomas B. Mental illness. In: Thomas B, British Dietetic Association, eds. Manual of Dietetic Practice, 3rd edn. London: Blackwell Publishing, 2002; 571-9.
5. Styron W. Darkness Visible. London: Jonathon Cape, 1991.
6. Bloch S, Singh B. Understanding Troubled Minds: A Guide to Mental Illness and Its Treatment. Melbourne: Melbourne University Press, 1997.
7. Garrow J, James W. Human Nutrition and Dietetics, 9th edn. London: Churchill Livingstone, 1993.
8. Information leaflet about antidepressants from the Royal College of Psychiarists. (Cited 13 Oct 2006.) Available from URL: http://www.rcpsych.ac.uk/mentalhealthinformation/mentalhealthproblems/ depression/antidepressants.aspx
9. Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Rasanen P. Fish consumption and depression: The Northern Finland 1966 birth cohort study. J Affect Disord 2004; 82: 447-52.
10. Hibbeln J, Salem N. Dietary polyunsaturated fats and depression: When cholesterol does not satisfy. Am J Clin Nutr 1995; 62: 1-9.
11. Baumel S. Dealing with Depression Naturally. Los Angeles, CA: Keats, 2000.
12. Murray C, Lopez A, eds. The Global Burden of Disease Study: A Comprehensive Assessment of Mortality and Disability from Disease, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press on behalf of the World Health Organization and the World Bank, 1996.
13. Weissman M, Bland R, Joyce P, Newman S, Wells J, Wittchen H. Sex differences in rates of depression: Cross-national perspectives. J Affect Disord 1993; 29: 77-84.
14. Wilhelm K, Mitchell P, Slade T, Brownhill S, Andrews G. Prevalence and correlation of DSM-IV major depression in an Australian National Survey. J Affect Disord 2003; 75: 155-62.
15. Andrews G, Sanderson K, Slade T, Issakidis C. Why does the burden of disease persist? Relating the burden of anxiety and depression to the effectiveness of treatment. Bull World Health Organ 2000; 78: 446-54.
16. Australian Health Insurance Commission. (Cited 14 Aug 2004.) Available from URL: http://www.hic.gov.au
17. Bloch S, Singh BS, eds. Foundations of Clinical Psychiatry. Melbourne: Melbourne University Press, 2000.
18. Joyce P, Mitchell P. Mood Disorders: Recognition and Treatment. Sydney: The University of New South Wales Press Ltd., 2004.
19. Taskforce on DSM IV. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 2000.
20. Ganong W. Review of Medical Physiology, 15th edn. Englewood Cliffs, NJ: Prentice Hall, 1991.
21. Marieb E. Human Anatomy and Physiology, 6th edn. San Francisco, CA: Pearson Benjamin Cummings, 2004.
22. Information leaflet about Neurotransmitters. (Cited 12 Nov 2005.) Available from URL: http://www.en.wikipedia.org/wiki/neurotransmitters
23. Bottiglieri T, Laundy M, Crellin R, Toone B, Carney M, Reynolds E. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69: 228-32.
24. Sullivan P, Neale M, Kendler K. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 2000; 157: 1552-65.
25. Bierut L, Heath A, Bucholz K et al. Major depressive disorder in a community-based twin sample: Are there different genetic and environmental contributions for men and women? Arch Gen Psychiatry 1999; 56: 557-63.
26. Nishizawa S, Benkelfat C, Young S et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 1997; 94: 5308-13.
27. Nolen-Hoeksema S. Sex differences in unipolar depression: Evidence and theory. Psychol Bull 1987; 101: 256-82.
28. Pope S, Watts J, Evans S, McDonald S, Henderson S. An Information Paper on Postnatal Depression: A Systematic Review of Published Scientific Literature to 1999. Canberra: National Health and Medical Research Council, 2000.
29. Evans J, Heron J, Francomb H, Oke S, Golding J. Cohort study of depressed mood during pregnancy and after childbirth. BMJ 2001; 323: 257-60.
30. O'Hara M, Swain A. Rates and risks of post-partum depression-a meta-analysis. Int Rev Psychiatry 1996; 8: 37-54.
31. Bloch M, Schmidt P, Danaceau M, Murphy J, Nieman L, Rubinow D. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000; 157: 924-30.
32. Dixon J, Dixon M, O'Brien P. Depression in association with severe obesity: Changes with weight loss. Arch Intern Med 2003; 163: 2058-65.
33. Zaider T, Johnson J, Cockell S. Psychiatric comorbidity associated with eating disorder symptomatology among adolescents in the community. Int J Eat Disord 2000; 28: 58-67.
34. O'Brien K, Vincent N. Psychiatric comorbidity in anorexia and bulimia nervosa: Nature, prevalence and causal relationships. Clin Psychol Rev 2003; 23: 57-74.
35. Sullivan P. Mortality in anorexia nervosa. Am J Psychiatry 1995; 152: 1073-4.
36. Keys A, Brozek J, Honschel A, Mickelson O, Taylor H. The Biology of Human Starvation. Minneapolis, MN: University of Minnesota Press, 1950.
37. International Obesity Task Force. 2004. (Cited 14 Aug 2004.) Available from URL: http://www.iotf.org
38. Wolpert L. Malignant Sadness. London: Faber and Faber; 1999.
39. Fernstrom JD. Can nutrient supplements modify brain function? Am J Clin Nutr 2000; 71: 1669S-73S.
40. Butterweck V. Mechanism of action of St John's Wort in depression: What is known? CNS Drugs 2003; 17: 539-62.
41. Crellin R, Bottiglieri T, Reynolds E. Folates and psychiatric disorders: clinical potential. Drugs 1993; 45: 623-36.
42. Tanskanen A, Hibbeln J, Hintikka J, Haatainen K, Honkalampi K, Viinamaki H. Fish consumption, depression and suicidality in general population. Arch Gen Psychiatry 2001; 58: 512-13.
43. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J. Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 2004; 161: 567-9.
44. O'Keefe H Jr, Harris W. From Inuit to implementation: Omega-3 fatty acids come of age. Mayo Clin Proc 2000; 75: 607-14.
45. Erasmus U. Fats that Heal, Fats that Kill. Burnaby, Canada: Alive Books, 1993.
46. Spector A, Yorek M. Membrane lipid composition and cellular function. J Lipid Res 1985; 26: 1015-35.
47. Alexander-North L, North J, Kiminyo K, Buettner G, Spector A. Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells. J Lipid Res 1994; 35: 1773-85.
48. Shepherd J, Patsch J, Packard C, Gotto A Jr, Taunton O. Dynamic properties of human high density lipoproteins apoproteins. J Lipid Res 1978; 19: 383-9.
49. Volker D, FitzGerald P, Major G, Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol 2000; 27: 343-6.
50. Simopoulos A. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot Essent Fatty Acids 1999; 60: 421-9.
51. Australian Bureau of Statistics. (Cited 14 Aug 2004.) Available from URL: http://www.abs.gov.au
52. Maes M, Smith R, Christophe A, Cosyns P. Fatty acid composition in major depression: Decreased omega-3 fractions in cholesteryl esters and increased C20:4 n-6/C20:5 n-3 ratio in cholesteryl esters and phospholipids. J Affect Disord 1996; 36: 35-46.
53. Maes M, Christophe A, Delanghe J, Altmura C, Neels H, Meltzer H. Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999; 85: 275-91.
54. Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998; 43: 315-19.
55. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998; 48: 149-55.
56. Nizzo M, Tegros S, Gallamini A, Toffano G, Polleri A, Massarotti M. Brain cortex phospholipids liposomes effects on CSF HVA, 5-HIAA and on prolactin and somatotropin secretion in man. J Neural Transmission 1978; 43: 93-102.
57. Youdim K, Martin A, Joseph J. Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci 2000; 18: 383-99.
58. Adams P, Lawson S, Sanigorski A, Sinclair A. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996; 31: S157-61.
59. Booth-Kewley S, Friedman H. Psychological predictors of heart disease: A quantitative review. Psychol Bull 1987; 101: 343-62.
60. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction, impact on 6 month survival. Am J Med 1993; 270: 819-25.
61. Marangell L, Martinez J, Zboyan H. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003; 160: 996-8.
62. Nemets B, Stahl Z, Belmaker R. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002; 159: 477-9.
63. Peet M, Horrobin D. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002; 59: 913-19.
64. Kremer J, Lawrence D, Petrillo G et al. Effects of high-dose fish-oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs: clinical and immune correlates. Arthritis Rheum 1995; 38: 1107-14.
65. Su K, Huang S, Chiu C, Shen W. Omega-3 fatty acids in major depressive disorder: A preliminary double blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003; 13: 267-71.
66. International Society for the Study of Fatty Acids and Lipids. N-3 fatty acids and depression. ISSFAL Newslett 2004; 11: 27-30.
67. Kris-Etherton P, Harris W, Appel L. Fish consumption, fish oil, omega-3 fatty acids and cardiovascular disease. Circulation 2002; 106: 2742-57.
68. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European Guidelines on cardiovascular disease prevention in clinical practice: 3rd Joint Task Force of the European and other societies of cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601-10.
69. Scientific Advisory Committee on Nutrition UK. (Cited 14 Aug 2004.) Available from URL: http://www.sacn.gov.uk/reports/
70. National Health and Medical Research Council (NHMRC). Report of the NHMRC Working Party: The Role of Polyunsaturated Fats in the Australian Diet. Canberra: AGPS, 1992.
71. National Heart Foundation of Australia. Review of the relationship between dietary fat and cardiovascular disease. Aust J Nutr Diet 1999; 56: S5-22.
72. ISSFAL Subcommittee 2004. Recommendations for intake of PUFA in healthy adults. ISSFAL Newslett 2004; 11: 12-25.
73. Bunker S, Colquhoun DM, Esler M et al. 'Stress'and coronary heart disease: Psychosocial factors-a National Heart Foundation of Australia position statement. Med J Aust 2003; 178: 272-6.
74. Simopoulos A. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002; 56: 365-79.
75. Wurtman J, Moses P, Wurtman R. Prior carbohydrate consumption affects the amount of carbohydrate that rats choose to eat. J Nutr 1983; 113: 70-78.
76. Sharp T, Bramwell S, Grahame-Smith D. Effect of acute administration of L-tryptophan on serotoninergic neuronal activity: An in vivo microdialysis study. Life Sci 1992, 1215-23.
77. Borbely A, Youmbi-Balderer G. Effects of tryptophan on human sleep. Interdisciplinary Top Gerontol 1987; 22: 111-27.
78. Young S, Gauthier S. Tryptophan availability and the control of 5-hydroxytryptamine and tryptamine synthesis in human CNS. Adv Exp Med Biol 1981; 133: 211-30.
79. Lyons P, Truswell AS. Serotonin precursor influenced by type pf carbohydrate meal in healthy adults. Am J Clin Nutr 1988; 47: 433-9.
80. Wurtman R, Wurtman J, Regan MM, McDermott J, Tsay R, Breu J. Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios. Am J Clin Nutr 2003; 77: 128-32.
81. Carney M, Chary T, Laundry M. Red cell folate concentrations in psychiatric patients. J Affect Disord 1990; 19: 207-13.
82. Morris M, Fava M, Jacques P, Selhub J, Rosenberg I. Depression and folate status in the US population. Psychother Psychosom 2003; 72: 80-87.
83. Bottiglieri T. S-Adenosyl-L-methionine (SAMe): From the bench to the bedside-molecular basis of a pleitrophic molecule. Am J Clin Nutr 2002; 76: 1151S-7S.
84. Lee S, Wing Y, Tong S. A controlled study of folate levels in Chinese inpatients with major depression in Hong Kong. J Affect Disord 1998; 49: 73-7.
85. Ramos M, Allen L, Haan M, Green R, Miller J. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin Nutr 2004; 80: 1024-8.
86. Tolmunen T, Voutilaimen S, Hintikka J et al. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr 2003; 133: 3233-6.
87. 12 status of the elderly. Eur J Clin Nutr 1996; 50: 340-42.
88. 12 level and good treatment outcome may be associated in major depressive disorder. BMC Psychiatry 2003; 3: 17-22.
89. 6 in clinical neurology. Ann N Y Acad Sci 1990; 585: 250-60.
90. 6 levels in depressed outpatients. Biol Psychiatry 1984; 19: 613-16.
91. 12 deficiency and depression in physically disabled older women: Epidemiologic evidence from Women's Health and Ageing Study. Am J Psychiatry 2000; 157: 715-21.
92. Bottiglieri T, Laundy M, Crellin R, Toone B, Carney M, Reynolds E. Homocysteine, folate, methylation and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69: 228-32.
93. 12 and homocysteine in major depressive disorders. Am J Psychiatry 1997; 153: 426-8.
94. 6 level is associated with symptoms of depression. Psychother Psychosom 2004; 73: 340-43.
95. 12, folate and homocysteine in depression: The Rotterdam Study. Am J Psychiatry 2002; 159: 2099-101.
96. Otero-Losado M, Rubio M. Acute effects of S-Adenosyl-L-methionine on catecholaminergic central function. Eur J Pharmacol 1989; 163: 355-6.
97. Otero-Losado M, Rubio M. Acute changes in 5HT metabolism after S-Adenosyl-L-methionine administration. Gen Pharmacol 1989; 20: 403-6.
98. Bottiglieri T, Laundy M, Martin R et al. S-Adenosyl-L-methionine influences monoamine metabolism. Lancet 1984; 2: 224.
99. Muccioli G, Scordamaiglia A, Di Carlo R. Effect of S-Adenosyl-L-methionine on brain muscarinic receptors. Eur J Pharmacol 1992; 227: 293-9.
100. Kowatch M, Roth G. Effect of specific membrane perturbations in alpha-adrenergic and muscarinic-cholinergic signal transduction in rat parotid cell aggregates. Life Sci 1994; 55: 2003-10.
101. Linde K, Ramerez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St. John's Wort for depression-an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253-8.
102. Gupta R, Moller H. St. John's Wort: An option for the primary care treatment of depressive patients? Eur Arch Psychiatry Clin Neurosci 2003; 253: 140-48.
103. Bilia A, Gallori S, Vincieri F. St. John's Wort and depression: efficacy, safety and tolerability-an update. Life Sci 2002; 70: 3077-96.